Sponsored Lunch Symposium by Eisai

5 Aug 2022 12:00 13:00
Join Now
Assoc. Prof. Dr. Zamri Zuhdi Chairperson
Time Session
12:00
13:00
The Possibility of Using Lenvatinib-based Therapy in Borderline Resectable/ Unresectable HCC Patients
Dr. Hsueh Kuan Chun Speaker Tung's Metro Harbor Hospital